ArticleThe Kobe journal of medical sciences2026
HBx Enhances the Nrf2/ARE-dependent Antioxidant Response by Promoting Nuclear Export and Downregulation of Bach1.
Article in The Kobe journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hepatitis B virus (HBV) infection disrupts redox homeostasis in hepatocytes and is associated with the development of liver diseases. We previously reported that HBV activates the nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway, a major cellular defense mechanism against oxidative stress. However, it remains unclear whether Bach1, a transcriptional repressor that antagonizes Nrf2, is involved in the HBV-induced activation of Nrf2/ARE pathway. In this study, we aimed to elucidate how HBV affects Bach1 expression and subcellular localization and how these changes contribute to activation of the Nrf2/ARE signaling pathway. ARE reporter assays revealed that Bach1 knockdown significantly enhanced HBx‑induced ARE activity, whereas Bach1 overexpression markedly attenuated it, indicating that Bach1 suppresses the HBx‑mediated antioxidant response. HBV infection and HBx expression reduced endogenous Bach1 protein levels without affecting Bach1 mRNA levels, suggesting post-transcriptional downregulation. Immunofluorescence and subcellular fractionation suggested that HBx contributes to HBV-induced Bach1 nuclear export. Co‑immunoprecipitation and immunofluorescence staining further demonstrated that HBx interacts with Bach1 in both the nucleus and cytoplasm. Notably, HBV infection upregulated the expression of NQO1, an Nrf2 target gene that was previously reported to contribute to HBx stabilization. In addition, Bach1 knockdown increased NQO1 and HBx protein levels. These findings suggest that Bach1 exerts an antiviral function by limiting Nrf2/ARE pathway activation and consequently restricting HBx stabilization. Collectively, our results suggest that HBx promotes nuclear export and downregulation of Bach1, thereby shifting the redox regulatory balance toward Nrf2 dominance, enhancing NQO1 expression, and stabilizing HBx protein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.